Impact of anti-VEGF therapy on distinctive retina layers in patients with macular edema secondary to branch retinal vein occlusion

[1]  Honghui He,et al.  Study of the Biological Developmental Characteristics of the Eye in Children After Laser Surgery for the Treatment of Retinopathy of Prematurity , 2022, Frontiers in Medicine.

[2]  S. Yoshida,et al.  Changes in metamorphopsia after the treat-and-extend regimen of anti-VEGF therapy for macular edema associated with branch retinal vein occlusion , 2020, PloS one.

[3]  J. Jonas,et al.  Retinal Pigment Epithelium Cell Density and Bruch’s Membrane Thickness in Secondary versus Primary High Myopia and Emmetropia , 2020, Scientific Reports.

[4]  K. Tsubota,et al.  Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

[5]  P. Lu,et al.  Association of glaucoma with risk of retinal vein occlusion: A meta‐analysis , 2019, Acta ophthalmologica.

[6]  Gui-Shuang Ying,et al.  Retinal Vein Occlusions Preferred Practice Pattern®. , 2019, Ophthalmology.

[7]  M. Leila,et al.  Grading of macular perfusion in retinal vein occlusion using en-face swept-source optical coherence tomography angiography: a retrospective observational case series , 2019, BMC Ophthalmology.

[8]  M. Shimura,et al.  Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion , 2019, Journal of ophthalmology.

[9]  E. Lucenteforte,et al.  Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. , 2018, The Cochrane database of systematic reviews.

[10]  Y. Kitaoka,et al.  Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab , 2018, PloS one.

[11]  Mark A. Christopher,et al.  Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients. , 2018, American journal of ophthalmology.

[12]  U. Schmidt-Erfurth,et al.  Neuroretinal atrophy following resolution of macular oedema in retinal vein occlusion , 2018, British Journal of Ophthalmology.

[13]  Or Segev,et al.  Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion. , 2017, American journal of ophthalmology.

[14]  Min-Su Kim,et al.  Repeatability of ganglion cell-inner plexiform layer thickness measurements using spectral-domain OCT in branch retinal vein occlusion , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  A. Goktas,et al.  Evaluation of foveal photoreceptor layer in eyes with macular edema associated with branch retinal vein occlusion after ozurdex treatment , 2017, International Ophthalmology.

[16]  F. Medeiros,et al.  Macular Ganglion Cell Inner Plexiform Layer Thickness in Glaucomatous Eyes with Localized Retinal Nerve Fiber Layer Defects , 2016, PloS one.

[17]  S. Harding,et al.  Defining response to anti-VEGF therapies in neovascular AMD , 2015, Eye.

[18]  J. Lai,et al.  The Correlation of Retinal Nerve Fiber Layer Thickness With Blood Pressure in a Chinese Hypertensive Population , 2015, Medicine.

[19]  A. Sharabi‐Nov,et al.  Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome , 2013, Journal of ophthalmology.

[20]  Nagahisa Yoshimura,et al.  Structural Changes in Individual Retinal Layers in Diabetic Macular Edema , 2013, Journal of diabetes research.

[21]  P. Keane,et al.  EVALUATION OF THE AXIAL LOCATION OF CYSTOID SPACES IN RETINAL VEIN OCCLUSION USING OPTICAL COHERENCE TOMOGRAPHY , 2013, Retina.

[22]  I. Chatziralli,et al.  BRANCH RETINAL VEIN OCCLUSION: Epidemiology, Pathogenesis, Risk Factors, Clinical Features, Diagnosis, and Complications. An Update of the Literature , 2013, Retina.

[23]  P. Khaw,et al.  VEGF-A Is Necessary and Sufficient for Retinal Neuroprotection in Models of Experimental Glaucoma , 2013, The American journal of pathology.

[24]  J. Jonas,et al.  The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study. , 2013, Ophthalmology.

[25]  C. Bunce,et al.  Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. , 2013, The Cochrane database of systematic reviews.

[26]  A. Tsujikawa,et al.  DISRUPTED FOVEAL PHOTORECEPTORS AFTER COMBINED CYSTOID SPACES AND RETINAL DETACHMENT IN BRANCH VEIN OCCLUSION TREATED WITH BEVACIZUMAB , 2012, Retina.

[27]  J. Haller,et al.  Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study. , 2012, Ophthalmology.

[28]  P. Campochiaro,et al.  Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. , 2012, Ophthalmology.

[29]  G. Wollstein,et al.  Profile and predictors of normal ganglion cell-inner plexiform layer thickness measured with frequency-domain optical coherence tomography. , 2011, Investigative ophthalmology & visual science.

[30]  K. Yau,et al.  Intrinsically photosensitive retinal ganglion cells. , 2010, Physiological reviews.

[31]  P. Campochiaro,et al.  Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.

[32]  Tien Yin Wong,et al.  The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. , 2010, Ophthalmology.

[33]  Sadaf Hamid,et al.  Branch Retinal Vein Occlusion , 2009 .

[34]  Kazuaki Miyamoto,et al.  Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion. , 2008, American journal of ophthalmology.

[35]  Vittorio Porciatti,et al.  Morphological and Functional Abnormalities in the Inner Retina of the rd/rd Mouse , 2002, The Journal of Neuroscience.

[36]  M. Ip,et al.  Retinal Vein Occlusion Review. , 2018, Asia-Pacific journal of ophthalmology.